Alcohol doesn’t just damage the liver — it locks its cells in a strange “in-between” state that prevents them from healing.

A new review in Biochemical Pharmacology synthesizes decades of research showing consistent links between regular coffee ...

While Ozempic and other drugs like it have proven effective in helping people lose weight, many gain it back when the ...

New data suggest antithymocyte globulin, verapamil, and baricitinib might help preserve beta cell function in new-onset type ...

Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

Roche is buying 89bio to get pegozafermin, a drug currently in two Phase 3 studies for the fatty liver disease MASH.

Anti-obesity drugs such as semaglutide (Ozempic, Wegovy) are also promising for the treatment of alcohol use disorder and ...

A research team has now tested a compound solid beverage formulated from Pu-erh tea extract, catechin, and theanine, finding ...

For decades, metformin has been the go-to medication for type 2 diabetes, prescribed to millions worldwide. Yet despite its ...

Roche acquires 89bio for up to $3.5B, betting on pegozafermin for MASH. Click here to read the latest analysis on ETNB and ...

The firm, which so far has focused on cancer, expects to file an IND application for a treatment for tyrosinemia type I and alkaptonuria next year.

Metformin has been prescribed to people with type 2 diabetes to manage blood sugar for more than 60 years, but scientists ...